Burkhart J G, Benziger J, Svensson K, Malling H V
Mutat Res. 1985 Jan-Feb;148(1-2):135-49. doi: 10.1016/0027-5107(85)90217-9.
We report that we are unable to repeat consistently the results published by Ansari et al. (1980) using antibodies to detect mutations in lactate dehydrogenase-C (LDH-C, previously called LDH-X) directly in sperm of mice exposed to the mutagen procarbazine. The approach made use of the interspecies differences in the antigenic sites between the LDH-C of the rat and mouse in sperm. The visualization of mutations in mouse LDH-C was based on the detection of alterations in antigenic sites of mouse LDH-C such that mouse sperm would bind the antibody that was specific for rat LDH-C (presumptive mutants); the antibody was termed specific when it immunofluorescently labeled rat sperm but not mouse sperm. The original work reported increases in the frequency of occurrence of mouse sperm that would bind rat-specific antibody from mice treated with procarbazine as compared control mice; a single absorbed antiserum was used throughout the experiments. In this study, we found that there is too much variation in the frequency of mouse sperm that react with rabbit antibodies to purified rat LDH-C for the system to be useful in mutagenesis studies. The fundamental criterion of antibody specificity was maintained as in the original work. The frequency of labeled mouse sperm depended on the absorption of the antibody on mouse proteins, indicating that the factors denoting a presumptive mutant were associated with the mouse proteins. In some experiments, the frequency of labeled mouse sperm was higher among sperm from procarbazine-treated mice than among sperm from control mice. This increase, however, was not consistently reproducible. After extensive absorption of the antibody on mouse proteins, no presumptive mutants were observed in sperm from treated and control animals; these antibodies continued to immunofluorescently label rat sperm. The absence of presumptive mutants with highly absorbed antibody suggests that natural variation between species may not be appropriate as markers for the detection of mutations without a thorough knowledge of the number of independent events at the DNA level required to produce a change in antigenic recognition.
我们报告称,我们无法始终如一地重复安萨里等人(1980年)发表的实验结果。他们使用抗体直接检测暴露于诱变剂甲基苄肼的小鼠精子中乳酸脱氢酶-C(LDH-C,以前称为LDH-X)的突变。该方法利用了大鼠和小鼠精子中LDH-C抗原位点的种间差异。小鼠LDH-C突变的可视化基于检测小鼠LDH-C抗原位点的改变,使得小鼠精子能够结合对大鼠LDH-C特异的抗体(推定突变体);当该抗体通过免疫荧光标记大鼠精子而不标记小鼠精子时,被称为特异性抗体。原始研究报告称,与对照小鼠相比,用甲基苄肼处理的小鼠中能结合大鼠特异性抗体的小鼠精子出现频率增加;整个实验使用了单一的吸收抗血清。在本研究中,我们发现与纯化的大鼠LDH-C的兔抗体发生反应的小鼠精子频率变化太大,以至于该系统在诱变研究中无用。如原始研究一样,维持了抗体特异性的基本标准。标记的小鼠精子频率取决于抗体在小鼠蛋白上的吸收情况,这表明表示推定突变体的因素与小鼠蛋白有关。在一些实验中,甲基苄肼处理小鼠的精子中标记的小鼠精子频率高于对照小鼠的精子。然而,这种增加并非始终可重复。在用小鼠蛋白对抗体进行广泛吸收后,在处理组和对照组动物的精子中均未观察到推定突变体;这些抗体继续通过免疫荧光标记大鼠精子。高度吸收的抗体未出现推定突变体,这表明在没有深入了解在DNA水平上产生抗原识别变化所需的独立事件数量的情况下,物种间的自然变异可能不适用于检测突变。